Raymond James Financial
CGON icon

Raymond James Financial’s CG Oncology CGON Stock Holding History

Raymond James Financial’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$751K Buy
11,090
+2,787
+34% +$158K ﹤0.01% 4072
2025
Q4 		$345K Buy
8,303
+1,005
+14% +$41.6K ﹤0.01% 4484
2025
Q3 		$294K Buy
7,298
+6,998
+2,333% +$203K ﹤0.01% 4427
2025
Q2 		$7.8K Buy
+300
New +$7.23K ﹤0.01% 6028

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Raymond James Financial's CGON Position: Q1 2026 in Review

Raymond James Financial increased its CG Oncology (CGON) stake by 34% in Q1 2026, buying an estimated $158K and bringing the position to 11,090 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #4072.

Raymond James Financial first reported a position in CGON in Q2 2025 and has held it in 4 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Raymond James Financial held 11,090 shares of CG Oncology worth $751K as of Q1 2026.
  • Raymond James Financial bought 2,787 CG Oncology shares in Q1 2026, an estimated $158K.
  • CG Oncology made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4072 holding.
  • Raymond James Financial first reported a position in CG Oncology in Q2 2025 and has held it in 4 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.